What is SunBio?
Established in 2005, SunBio Corporation is dedicated to developing nutraceutical products rooted in scientific research and natural ingredients. Their flagship ingredient, Decursinol-50, is formulated to alleviate pain and enhance joint health, aligning with the company's core values of good health, scientific innovation, and natural healing. SunBio aims to provide rejuvenating solutions, targeting consumers who prefer natural alternatives over pharmaceutical interventions for their health and wellness needs.
How much funding has SunBio raised?
SunBio has raised a total of $202K across 1 funding round:
Debt
$202K
Debt (2025): $202K, investors not publicly disclosed
What's next for SunBio?
The substantial capital infusion, particularly the recent strategic investment, positions SunBio for accelerated growth and market penetration. This large-scale, late-stage funding suggests the company is poised to expand its product development pipeline, enhance its manufacturing capabilities, and broaden its distribution channels. SunBio's focus on scientifically validated, natural ingredients for joint health is a key differentiator in a growing market, and this backing will likely fuel further innovation and market leadership.
See full SunBio company page
